UBS Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,147
| Closed | -$29.7K | – | 8957 |
|
|
2025
Q1 | $29.7K | Sell |
3,147
-1,467
| -32% | -$13.8K | ﹤0.01% | 6657 |
|
|
2024
Q4 | $56.8K | Sell |
4,614
-731
| -14% | -$9K | ﹤0.01% | 6000 |
|
|
2024
Q3 | $79.9K | Buy |
5,345
+5,207
| +3,773% | +$77.8K | ﹤0.01% | 5319 |
|
|
2024
Q2 | $1.86K | Sell |
138
-343
| -71% | -$4.63K | ﹤0.01% | 7307 |
|
|
2024
Q1 | $7.99K | Sell |
481
-1,380
| -74% | -$22.9K | ﹤0.01% | 6179 |
|
|
2023
Q4 | $25.1K | Sell |
1,861
-38
| -2% | -$512 | ﹤0.01% | 5757 |
|
|
2023
Q3 | $20.8K | Sell |
1,899
-866
| -31% | -$9.49K | ﹤0.01% | 5647 |
|
|
2023
Q2 | $35.7K | Buy |
2,765
+1,283
| +87% | +$16.6K | ﹤0.01% | 5579 |
|
|
2023
Q1 | $17.8K | Sell |
1,482
-1,262
| -46% | -$15.1K | ﹤0.01% | 6075 |
|
|
2022
Q4 | $37.7K | Buy |
2,744
+203
| +8% | +$2.79K | ﹤0.01% | 5862 |
|
|
2022
Q3 | $37K | Buy |
2,541
+1,080
| +74% | +$15.7K | ﹤0.01% | 5551 |
|
|
2022
Q2 | $22K | Buy |
+1,461
| New | +$22K | ﹤0.01% | 5715 |
|
|
2022
Q1 | – | Sell |
-1,249
| Closed | -$30K | – | 9206 |
|
|
2021
Q4 | $30K | Sell |
1,249
-325
| -21% | -$7.81K | ﹤0.01% | 6283 |
|
|
2021
Q3 | $48K | Buy |
+1,574
| New | +$48K | ﹤0.01% | 5264 |
|
|
2021
Q1 | – | Sell |
-806
| Closed | -$26K | – | 7939 |
|
|
2020
Q4 | $26K | Buy |
806
+415
| +106% | +$13.4K | ﹤0.01% | 5734 |
|
|
2020
Q3 | $11K | Sell |
391
-1,764
| -82% | -$49.6K | ﹤0.01% | 5877 |
|
|
2020
Q2 | $58K | Buy |
+2,155
| New | +$58K | ﹤0.01% | 4899 |
|
|
2020
Q1 | – | Sell |
-139
| Closed | -$3K | – | 7016 |
|
|
2019
Q4 | $3K | Buy |
+139
| New | +$3K | ﹤0.01% | 6656 |
|
|
2019
Q2 | – | Sell |
-2,349
| Closed | -$49K | – | 6976 |
|
|
2019
Q1 | $49K | Buy |
2,349
+137
| +6% | +$2.86K | ﹤0.01% | 4749 |
|
|
2018
Q4 | $42K | Sell |
2,212
-45
| -2% | -$854 | ﹤0.01% | 5341 |
|
|
2018
Q3 | $56K | Sell |
2,257
-412
| -15% | -$10.2K | ﹤0.01% | 5192 |
|
|
2018
Q2 | $64K | Buy |
2,669
+2,319
| +663% | +$55.6K | ﹤0.01% | 4908 |
|
|
2018
Q1 | $10K | Buy |
+350
| New | +$10K | ﹤0.01% | 5966 |
|
|
2017
Q1 | – | Sell |
-1,141
| Closed | -$24K | – | 6685 |
|
|
2016
Q4 | $24K | Buy |
+1,141
| New | +$24K | ﹤0.01% | 5458 |
|
|
2016
Q2 | – | Sell |
-769
| Closed | -$17K | – | 6789 |
|
|
2016
Q1 | $17K | Sell |
769
-109
| -12% | -$2.41K | ﹤0.01% | 5478 |
|
|
2015
Q4 | $25K | Buy |
+878
| New | +$25K | ﹤0.01% | 5358 |
|